Labshake search
Citations for Invivogen :
1 - 50 of 361 citations for 8 CHLOROQUINOLIN 2 AMINE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2022Quote: ... an imidazoquinoline amine analog to guanosine (Invivogen). TLR9 or TLR7 activation was normalized to SEAP levels produced by infected null1 parental cells and is expressed as the fold-change over mock infected controls ...
-
bioRxiv - Immunology 2020Quote: ... plus the TLR-7 and TLR-8 agonist Resiquimod (R848, 2 µM, InvivoGen), for 24 h ...
-
bioRxiv - Microbiology 2023Quote: ... TLR7/8 agonist (R848, 8 μg/mL, InvivoGen) or exposed to vRNPs in virus-cleared SN from infected (24 hpi ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-ppp-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (Catalog Code, lyec-12, InvivoGen), following the manufacturer’ ss instructions ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) in growth medium for 5 days at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Immunology 2023Quote: ... HEK-293T cells overexpressing hTLR7/8 (HEK-Blue-TLR7/8) were purchased from InvivoGen (San Diego, California, USA) and cultured in DMEM supplemented with 10% (vol/vol ...
-
bioRxiv - Immunology 2021Quote: ... a specific TLR7/8 agonist (5μM, Invivogen) as positive control ...
-
bioRxiv - Immunology 2023Quote: ... diABZI (Invivogen, cat no. 2138299-34-8), 2’3’-cGAMP (Invivogen ...
-
bioRxiv - Immunology 2024Quote: ... TLR7/8 agonist (R848 ; Invivogen, cat #tlrl-r848) at 0,5 μg/mL each ...
-
bioRxiv - Bioengineering 2023Quote: ... 4 or 8 µg/ml) or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Immunology 2024Quote: ... BMDMs were further incubated with Nigericin (8 μM, Invivogen) for an additional 90 minutes.
-
bioRxiv - Neuroscience 2024Quote: ... for 8 hours and ATP (10nM)(InvivoGen, tlrl-atpl) for 30 minutes ...
-
bioRxiv - Immunology 2021Quote: ... and 8 μg of CpG (Cat: TLRL-1826-1, Invivogen) were administered to mice on days 0 and 14 ...
-
bioRxiv - Immunology 2020Quote: ... and R848 (TLR7/8; tlrl-r848; Invivogen, 100 ng/ml) for 4 hours ...
-
bioRxiv - Immunology 2022Quote: ... the medium was supplemented with 8 μg/ml blasticidin (Invivogen). 4T1 and 4T1-Luc2 cells were transfected with a plasmid DNA encoding a fusion protein of the nucleoproteins of SARS-CoV-2 and MERS-CoV (non-secreted form ...
-
bioRxiv - Neuroscience 2023Quote: ... Puromycin (Puro, 0.5 - 8 µg/mL Invivogen, ant-pr-1), Doxycycline hyclate (Dox ...
-
bioRxiv - Immunology 2023Quote: ... or 10 µM of TLR 8 inhibitor (Cu-CPT9a, Invivogen) were incubated with MDMs 3h prior to infection ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 8 and 9 cell lines were purchased from InvivoGen (Hong Kong). The cells express the human TLR gene and NF-κB/AP-1-inducible SEAP (secreted embryonic alkaline phosphatase ...
-
bioRxiv - Pathology 2020Quote: ... followed by antibiotic-mediated selection (8 μg/mL puromycin, Invivogen, #ant-pr).
-
bioRxiv - Immunology 2022Quote: ... 2 ug/mL Pam3CSK4 (TLR1/2 agonist, Invivogen), and 1 ug/mL FSL-1 (TLR2/6 agonist ...
-
bioRxiv - Bioengineering 2021Quote: ... and 2 µl/ml primicin (Ant-pm-2, InvivoGen) at 37°C for 19 hours.
-
bioRxiv - Bioengineering 2022Quote: ... and 2 μl/ml primocin (Ant-pm-2, InvivoGen) at 37°C for 19 hours ...
-
bioRxiv - Neuroscience 2021Quote: ... one from Invivogen of high molecular weight (HMW) (1.5 kb – 8 kb) and one from Invivogen of low molecular weight (LMW ...
-
bioRxiv - Immunology 2021Quote: ... Cells were then stimulated with the TLR-7/8 agonist Resiquimod – R848 (Invivogen) at 5 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... 1×106 PBMC were stimulated with 1ug/ml R848 (TLR7/8 agonist; Resiquimod (Invivogen)) diluted in complete RPMI (cRPMI ...
-
bioRxiv - Bioengineering 2022Quote: ... and stimulated with 1 μg/mL R848 (TLR7/8 agonist; InvivoGen, Inc.; San Diego, CA) and 5 μg/mL of CD40 antibody ligand (clone ...
-
bioRxiv - Cell Biology 2019Quote: ... 2’,3’-cGAMP (Invivogen) at 10 μg/mL ...
-
bioRxiv - Molecular Biology 2021Quote: ... or on solid YPD-agar (1% yeast extract, 2% peptone, 2% D-glucose, 2% agar) and selected with 100 µg/ml Zeocin® (InvivoGen). For small scale expression screening ...
-
bioRxiv - Developmental Biology 2019Quote: ... followed by selection using 2 μg/ml of puromycin (Invivogen, 58-58-2) for 2–3 days starting from 2 days after infection ...
-
bioRxiv - Immunology 2020Quote: ... or 500 ng high molecular weight poly(I:C) (InvivoGen tlrl-pic, 1.5 kb to 8 kb) using Lipofectamine 2000 (ThermoFisher 11668 ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP) (Invivogen cat. no. tlrl-nacga23), and human IFN-β (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... or Alum (Alhydrogel 2%, InvivoGen) at 50% v/v at final volume of 30µl per dose ...
-
bioRxiv - Immunology 2020Quote: ... R848 (2 μg/mL, InvivoGen), CHIKV-LR at a multiplicity of infection (MOI ...
-
bioRxiv - Cancer Biology 2022Quote: ... supplemented with 2% Primocin (Invivogen) at 4°C and transported on ice to be processed within 24 hours for organoid culture ...
-
bioRxiv - Molecular Biology 2023Quote: ... THP-1 Null 2 (InvivoGen), THP-1 Null 2 NLRP3 KO (InvivoGen ...
-
bioRxiv - Biochemistry 2023Quote: ... puromycin (2 µg/ml, InvivoGen), blasticidin (10 µg/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 2% Primocin (Invivogen) at 4°C and transported on ice to be processed within 24 hours for organoid culture ...
-
bioRxiv - Immunology 2022Quote: ... and the TLR9 agonist ODN2395 and the TLR7/8 agonist R848 (both from Invivogen, San Diego, CA), the positive controls ...
-
bioRxiv - Immunology 2023Quote: Spike proteins (2 μg/dose) were formulated with Alhydrogel 2% (InvivoGen, San Diego, CA, USA) as previously described (20) ...
-
bioRxiv - Immunology 2023Quote: Mice of the C57BL/6 genetic background (8 – 14 weeks old) were immunised with EndoFit Ovalbumin (OVA) (Invivogen) or SARS-CoV-2 RBD ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA) (Invivogen cat. no. tlrl-nacda2r), 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP ...
-
bioRxiv - Cell Biology 2020Quote: ... and doxycycline (Invivogen, 2 mM stock) were dissolved in water.
-
bioRxiv - Pathology 2019Quote: ... 0.5mL primocin (Invivogen ant-pm-2), BDNF (10ng/mL ...
-
bioRxiv - Microbiology 2020Quote: ... with Primocin (InvivoGen, ant-pm-2), and then digested with Collagenase II (Gibco ...
-
bioRxiv - Neuroscience 2019Quote: ... Blasticidin selection (2 μg/ml, InvivoGen) was started 2–4 days after plating of cells and picking of clones was started 10–14 days after nucleofection ...
-
bioRxiv - Bioengineering 2021Quote: ... and Alhydrogel adjuvant 2% (alum, InvivoGen) were used for vaccination studies ...
-
bioRxiv - Genomics 2021Quote: ... and 2 mg/ml puromycin (InvivoGen) were added 24h after infection ...